Drugs / plasma rich in growth factors
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05837494 Comparator | Jun 2022 → May 2023 | osteoarthritis, knee | Tanta University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plasma rich in growth factors | “injection of already synthetic plasma rich in growth factors \[PRGF\] vial intra-articularly.” NCT05837494 ↗ |
| Known as | PRGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05837494 ↗ |
| Modality | Protein / enzyme biologic | “lyophilized cake of platelet growth factors” NCT05837494 ↗ |
| Route | Other | “vial intra-articularly” NCT05837494 ↗ |